Compare
Paysign, Inc. vs OptimizeRx Corp vs Bridger Aerospace Group Holdings, Inc. vs DHI Group, Inc.
| Latest fiscal year | Paysign, Inc. PAYS | OptimizeRx Corp OPRX | Bridger Aerospace Group Holdings, Inc. BAER | DHI Group, Inc. DHX |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $82.03M | $109.43M | $122.83M | $127.83M |
| Revenue growth (YoY) | +40.5% | +18.8% | +24.6% | -9.9% |
| Gross margin | 59.4% | 67.3% | 42.1% | 84.7% (computed) |
| Operating margin | 9.0% | 10.7% | n/a | -8.9% |
| Net margin | 9.2% | 4.7% | 3.4% | -10.6% |
| Net income | $7.55M | $5.13M | $4.14M | -$13.51M |
| EPS (Diluted) | $0.13 | $0.27 | -$0.42 | -$0.30 |
| Operating cash flow | $52.45M | $18.71M | $16.73M | $21.10M |
| Free cash flow | $51.24M | $18.66M | -$64.21M | $13.79M |
| Cash & equivalents | n/a | $23.36M | $31.38M | $2.91M |
| Total assets | $276.25M | $176.92M | $330.31M | $188.24M |
| Total liabilities | $227.76M | $48.62M | $265.64M | $93.74M |
| Shareholders' equity | $48.49M | $128.29M | -$342.59M | $94.51M |
| Return on year-end equity | 15.6% | 4.0% | n/a | -14.3% |
| Shares outstanding | 55.09M | 18.76M | 55.89M | 44.46M |
Revenue, most recent five fiscal years
| Fiscal year | Paysign, Inc. | OptimizeRx Corp | Bridger Aerospace Group Holdings, Inc. | DHI Group, Inc. |
|---|---|---|---|---|
| Latest | $82.03M Ended 2025-12-31 | $109.43M Ended 2025-12-31 | $122.83M Ended 2025-12-31 | $127.83M Ended 2025-12-31 |
| 1 year earlier | $58.38M Ended 2024-12-31 | $92.13M Ended 2024-12-31 | $98.61M Ended 2024-12-31 | $141.93M Ended 2024-12-31 |
| 2 years earlier | $47.27M Ended 2023-12-31 | $71.52M Ended 2023-12-31 | $66.71M Ended 2023-12-31 | $151.88M Ended 2023-12-31 |
| 3 years earlier | $38.03M Ended 2022-12-31 | $62.45M Ended 2022-12-31 | $46.39M Ended 2022-12-31 | $149.68M Ended 2022-12-31 |
| 4 years earlier | $29.46M Ended 2021-12-31 | $61.29M Ended 2021-12-31 | n/a | $119.90M Ended 2021-12-31 |